Extracellular Vesicle for Tumor Targeting Delivery System and Tumor Immunotherapy
A special issue of Bioengineering (ISSN 2306-5354).
Deadline for manuscript submissions: closed (16 December 2022) | Viewed by 4900
Special Issue Editors
Interests: tumor therapy; tumor immunology; metabolism; extracellular vesicles
Special Issue Information
Dear Colleagues,
Since Dr. Peter Wolf first proposed "platelet dust" in 1967, extracellular vesicles (EVs) have been gradually known by us. EVs (including plasma membrane derived microparticles and endosomal derived exosomes) play an important role on information exchange between cells through contained protein, lipids and RNA or DNA. In recent years, due to its histocompatibility, natural carrier characteristics and its removability, EV has been widely used in tumor targeted drug delivery and immunotherapy. This special issue mainly collects research papers, reviews or comments on extracellular vesicles in drug delivery and immunotherapy on tumor, as well as related bioengineering and clinical translational study.
Dr. Ke Tang
Prof. Dr. Honglin Jin
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- extracellular vesicles
- exosome
- tumor targeted therapy
- tumor drug delivery
- tumor immunotherapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
